iMBIORAY

Hangzhou, China · Founded 2014 · Privately Held (backing)

Developer of innovative drugs intended for the treatment of tumors and immune diseases. iMBIORAY is based in Hangzhou, China and was founded in 2014. It has raised $90.9 million.

Last price · $/share
—
Implied valuation
—
Total raised
$90.9M
Last round
—
Valuation — not yet established

No valuation for iMBIORAY is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($90.9M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of iMBIORAY with a free account
  • ·The complete investor list: 15 names
  • ·Watch iMBIORAY: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

iMBIORAY funding history

No rounds on record

No funding rounds for iMBIORAY are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How iMBIORAY's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For iMBIORAY, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about iMBIORAY

How much has iMBIORAY raised?
iMBIORAY has raised $90.9M in total funding across its recorded rounds.